Aug 18, 2026
Flashwater Biosciences is pleased to announce that research relevant to its hypochlorous acid (HOCl) oral-care technology has been featured by Oral Health Group, a Canadian professional dental media publication, in the article “A Better Story for Oral and Biological Health: From Antimicrobial Force to Ecological Regulation.”
Written by Janice Goodman, DDS, MSc, and published on March 11, 2026, the article explores an important shift in oral care: moving beyond broad antimicrobial force toward more targeted management of biofilms and the oral microbial environment.

The mouth contains a complex microbial community, and oral health depends on more than simply removing as many microorganisms as possible. The Oral Health Group feature presents an ecological perspective in which effective oral hygiene should help control harmful biofilms while taking the wider oral environment into account.
Within this framework, HOCl is discussed as a biologically familiar antimicrobial molecule. HOCl is naturally generated by immune cells as part of the body’s innate defense response. Its relevance to oral care is increasingly being studied because of its activity against microbial communities and biofilms.
The article describes HOCl as a potential ecological modulator rather than merely a conventional broad-spectrum antimicrobial. This distinction supports a more balanced oral-care narrative focused on biofilm control, tissue compatibility and responsible daily hygiene.
The professional media coverage follows peer-reviewed research published in the Journal of Oral Microbiology under the title “Hypochlorous acid solution serves as a potential anti-biofilm therapy for periodontitis via targeting quorum sensing of periodontal pathogens.”
The study investigated the activity of hypochlorous acid solution against periodontal pathogenic biofilms and examined potential mechanisms involving quorum sensing—the chemical communication system bacteria use to coordinate biofilm development and behavior.
According to the published findings, the tested HOCl solution demonstrated anti-biofilm activity in laboratory models. In the study’s preclinical in vivo model, treatment was also associated with reduced plaque accumulation and periodontal inflammation, together with reduced alveolar bone resorption. These findings support continued scientific investigation of HOCl-based approaches to periodontal biofilm management.
The study is indexed by PubMed, the biomedical literature database maintained by the U.S. National Library of Medicine. PubMed indexing and publication in a peer-reviewed journal make the research accessible to dental professionals, researchers and distribution partners seeking verifiable scientific information.
Flashwater Mouthwash is formulated with HOCl and supplied as a 1-liter concentrate with a 1:14 dilution ratio, providing up to approximately 500 uses per bottle depending on the amount used per rinse.
The product is intended for routine oral hygiene. Its development is informed by research into several important areas of mouthwash performance, including:
These criteria provide a useful framework for professional product evaluation. Individual product claims should always be considered in light of the applicable test methods, formulation, concentration, directions for use and regulatory requirements in each market.
To support structured commercial evaluation, Flashwater Biosciences is offering a limited complimentary product allocation to qualified U.S. partners, including pharmacies, dental clinics, traditional Chinese medicine clinics, beauty and wellness retailers, and oral-care distributors.
Qualified organizations may request up to 10 bottles at no product cost. Domestic shipping charges apply, and no purchase obligation is attached to the allocation. The suggested retail price is USD $49.99 per bottle, while distributor pricing begins at approximately 50% of retail, with preferential terms available for volume commitments.
Interested organizations may contact Flashwater Biosciences with their business name, business type, U.S. shipping address and requested quantity. Allocations are subject to inventory availability and partner qualification.
Flashwater Biosciences, operated by Nantong Flashwater Biotechnology Co., Ltd., develops HOCl-based oral-hygiene solutions informed by current biofilm and oral-health research. The company works with practitioners, distributors and research partners to advance responsible product evaluation and evidence-based oral-care communication.
Professional media coverage:
Oral Health Group — A Better Story for Oral and Biological Health: From Antimicrobial Force to Ecological Regulation
Peer-reviewed research:
Lv X. et al. “Hypochlorous acid solution serves as a potential anti-biofilm therapy for periodontitis via targeting quorum sensing of periodontal pathogens.” Journal of Oral Microbiology. 2025;17(1):2557959. PubMed record | DOI
Product disclaimer: Flashwater Mouthwash is an oral-hygiene product manufactured in an FDA-registered facility. It is not intended to diagnose, treat, cure or prevent any disease. References to published research are provided for scientific and educational purposes and should not be interpreted as approval by Oral Health Group, PubMed, the U.S. National Library of Medicine or any government agency.
SEO Title: Flashwater HOCl Research Featured by Canada’s Oral Health Group
Meta Description: Canadian dental publication Oral Health Group highlights peer-reviewed HOCl research on oral biofilms, ecological regulation and periodontal health.
Suggested URL Slug: flashwater-hocl-research-oral-health-group-canada
Suggested Image Alt Text: Flashwater HOCl mouthwash and six evaluation standards for oral biofilm management and oral tissue compatibility.